Loading clinical trials...
Loading clinical trials...
A Randomized, Single-Dose, Four-Treatment Crossover Bioequivalence and Food Effect Study of Test Formulation of Cetirizine 10mg Chewable Tablets Versus Two Marketed Cetirizine 10mg Immediate Release Tablets.
Conditions
Interventions
Cetirizine 10mg
Cetirizine 10 mg
+1 more
Locations
1
Canada
Algorithme (An altascience Company)
Mount Royal, Quebec, Canada
Start Date
December 11, 2018
Primary Completion Date
February 3, 2019
Completion Date
February 3, 2019
Last Updated
December 1, 2021
NCT06406114
NCT06993103
NCT06771440
NCT06732414
NCT05271318
NCT06560255
Lead Sponsor
Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions